Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
A1480LS
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | A1480LS is a peripherally restricted, orally active covalent and irreversible inhibitor of both DAGLα and DAGLβ, exhibiting IC50 values of 6 nM and 4 nM at human targets, respectively, and IC50 values ≤15 nM across mice, rats, dogs, monkeys, and human systems. A1480LS reduces levels of 2-arachidonoylglycerol, arachidonic acid, and eicosanoids derived from cyclooxygenase and lipoxygenase pathways. It inhibits the injury-induced production of 2-arachidonoylglycerol and arachidonic acid in peripheral sciatic nerves and reduces the response of high-threshold and wide dynamic range-like dorsal horn neurons to mechanical stimuli. Moreover, A1480LS alleviates pain behaviors in rat models of inflammatory pain, neuropathic pain, and chemotherapy-induced peripheral neuropathy. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.